...
首页> 外文期刊>European journal of ophthalmology >Phacoemulsification in previously vitrectomized patients: an analysis of the surgical results in 100 eyes as well as the factors contributing to the cataract formation.
【24h】

Phacoemulsification in previously vitrectomized patients: an analysis of the surgical results in 100 eyes as well as the factors contributing to the cataract formation.

机译:先前接受玻璃体切除术的患者行超声乳化:分析100眼的手术结果以及导致白内障形成的因素。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the safety and effectiveness of phacoemulsification with clear corneal incision in previously vitrectomized patients as well as factors affecting the development time and type of cataract occurring after pars plana vitrectomy (PPV). METHODS: The authors conducted a prospective study of 100 consecutive eyes of patients who developed a cataract after PPV. Three groups were established based on the underlying vitreoretinal pathology. The main outcome measurements were intraoperative and postoperative complications and changes in best-corrected visual acuity (BCVA). RESULTS: The median interval between PPV and phacoemulsification was 11.5 months. Patients with proliferative diabetic retinopathy required phacoemulsification earlier (p=0.018). Posterior subcapsular cataracts developed more frequently in patients <50 years (73.7%, p=0.000) and affected those who underwent vitrectomy primarily for complicated retinal detachment (48.8%, p=0.046). Intraoperative complications included posterior capsular tears (4%), luxated nucleus into vitreous (2%), and zonular dialysis (5%). Postoperative complications were vitreous hemorrhage (6%), retinal redetachment (4%), pupillary synechiae (6%), ocular hypertension (4%), and Seidel phenomenon (3%). Posterior Nd:YAG laser capsulotomy was required in 44% of eyes. BCVA was improved in 85% of cases at the end of follow-up (median, 15.5 months). Twenty-one patients with one functioning eye (61.9%) demonstrated visual improvement compared with 79 patients with bilateral vision (91.1%; p=0.003). CONCLUSIONS: The technique allows stable improvement in BCVA through long follow-ups. It is more risky than in nonvitrectomized eyes. The visual results after phacoemulsification in vitrectomized eyes seem to be limited by retinal comorbidity and surgical complications.
机译:目的:评估在透明玻璃体切除术患者中进行透明角膜切口超声乳化术的安全性和有效性,以及影响平板玻璃体切除术(PPV)后发生白内障发生时间和类型的因素。方法:作者对PPV后发生白内障的100只连续眼睛的患者进行了前瞻性研究。根据潜在的玻璃体视网膜病理学分为三组。主要结局指标为术中和术后并发症以及最佳矫正视力(BCVA)的变化。结果:PPV与超声乳化术之间的中位间隔为11.5个月。患有增生性糖尿病视网膜病变的患者需要更早进行超声乳化(p = 0.018)。在<50岁的患者中,后囊膜下白内障的发生率更高(73.7%,p = 0.000),并影响了那些因复杂的视网膜脱离而进行玻璃体切割的患者(48.8%,p = 0.046)。术中并发症包括后囊撕裂(4%),髓核剥落成玻璃体(2%)和小带透析(5%)。术后并发症为玻璃体出血(6%),视网膜脱离(4%),瞳孔粘连(6%),高眼压(4%)和塞德尔现象(3%)。在44%的眼睛中需要进行Nd:YAG后视激光囊切开术。在随访结束时(中位数为15.5个月),BCVA改善了85%。 21例具有一只功能性眼的患者(61.9%)表现出视力改善,而79例具有双眼视力的患者(91.1%; p = 0.003)。结论:该技术可通过长期随访稳定改善BCVA。它比没有玻璃体切除术的眼睛风险更高。晶状体切除术的眼睛进行超声乳化手术后的视觉结果似乎受到视网膜合并症和手术并发症的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号